PANDA’s co-founder, Nick Hudson, was the keynote speaker at the March 2020 inaugural BizNews Investment Conference in South Africa. His talk negates the fear and gives clear reasons why the only thing to fear is fear itself in the story of the Covid-19 pandemic response.
Nick Hudson, co-founder of PANDA, speaks to Alec Hogg on the AstraZeneca vaccine and the sudden resignation of Salim Karim.
PANDA’s Nick Hudson in conversation with Sanjeev Sabhlok, moral philosopher and economist based in Melbourne, Australia. After many years in civil service in both India and Australia, Sanjeev left the civil service to protest the Victorian government’s pandemic policies.
At stake is a crucial aspect of free speech. Though the Daily Maverick may consider PANDA’s speech inconvenient, it certainly does not constitute hate speech or defamation – two accepted limitations on free speech. The clear intention of the Daily Maverick article is to silence PANDA’s voice. Publishing personal information about selected members and their employers knowing that it was irrelevant to the topic of the article can have had no other purpose.
Dr Knut Wittkowski is a German epidemiologist and former Head of Biostatics, Epidemiology and Research Design at Rockefeller University.
Jarrette Petzer from Move One Million interviews Nick Hudson on Facebook Live.
Covid facts to lift us out of fear and give us hope of returning to normality in South Africa.
‘Many who were angered by our original points about lockdown, now own up to agreeing with them, but have dug up other reasons for carrying on being angry with us.’
With our government and political-elites having now reached the odd milestone of stifling the country in over 300 days of lockdown; we ask the question, did this “#StopTheSpread” of the Corona virus? What does the evidence and data tell us about the effectiveness of “lockdowns” and other Non-Pharmaceutical Interventions (NPI)?
Nick Hudson (PANDA) joins the Burning Platform to discuss what the data suggest about the effectiveness of lockdowns on a cost-to-benefit ratio. There’s a discussion around the media’s role in stoking pandemic panic, before moving on to the subject of a vaccine – its viability given a rapid public uptake after an equally rapid turnaround, and big Pharma’s push to get a solution to market without it first being peer reviewed.
Jay Bhattacharya, member of PANDA’s Scientific Advisory Board and Professor of Economics and Medicine at Stanford University, in conversation with Nick Hudson.